Literature DB >> 453486

Occupational allergy in nurses to a bulk laxative.

L Machado, O Zetterström, E Fagerberg.   

Abstract

Finely ground psyllium (Plantago ovata) seeds, so-called ispaghula powder is used in bulk laxatives. During the dispensing of these medicines some dust is generated. Allergic symptoms from exposure to this dust was reported by two nurses, one of whom was wroking in a department where exposure to the powder could be considered high. Nineteen other subjects working in the same department were investigated with regard to allergy to ispaghula powder. An extract from ispaghula powder was made and used in RAST and skin tests. Exposure tests with ispaghula powder mixed with crushed rusks were made in symptomatic subjects. Eight out of the 20 investigated subjects from this department reported symptoms which could possibly have been elicited by ispaghula powder. Evidence of sensitization was found in five of them. The use of less dusty (granulated) forms of ispaghula laxatives might diminish the risk of sensitization.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 453486     DOI: 10.1111/j.1398-9995.1979.tb02000.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

Review 1.  In vitro assays for immunoglobulin E. Methodology, indications, and interpretation.

Authors:  S G Johansson; L Yman
Journal:  Clin Rev Allergy       Date:  1988

2.  Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy.

Authors:  O Zetterström; K Osterman; L Machado; S G Johansson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-07

3.  Psyllium allergy in hospital personnel: a report on twelve patients.

Authors:  Z Jancelewicz; J Dolovich; G L Sussman
Journal:  Can Fam Physician       Date:  1988-03       Impact factor: 3.275

Review 4.  Adverse effects of drugs used in the management of constipation and diarrhoea.

Authors:  J M Gattuso; M A Kamm
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.